BU-NOT-SET

CONTACT US
The QbD approach: Key advantages in clinical and commercial phases
  • Analytical chemistry
Lab
Insight
Sustainability report 2020
  • Sustainability
Report
Report
Recipharm and Oncopeptides: Successful collaboration in the development of melflufen, a peptidase-potentiated alkylating agent in clinical trials
  • Drug substance
Man at poster
Poster
Recipharm Analytical Solutions™
  • Analytical chemistry
Icon
Fact sheet
Impurity identification
  • Analytical chemistry
Woman inserting vials in machine
Fact sheet
Stability studies
  • Analytical chemistry
hand holding vials plate
Fact sheet
Extractables & leachables testing
  • Analytical chemistry
Product mix
Fact sheet
Pharmaceutical mergers and acquisitions: opportunities and drivers for CDMOs
  • Industry trends
Eyes
Insight
Global expansion in the CDMO field
  • Industry trends
Eyes
Insight
Case study
  • Drug product
Avoiding pitfalls in sterile manufacturing
Webinar
  • Drug substance
How to develop a cannabinoid into a drug
eBook
  • Drug product
Golden rules for drug development
Fact sheet
  • Drug product
  • Manufacturing
Packaging services
Insight
  • Manufacturing
How has the pharmaceutical industry been affected by the pandemic?
Insight
  • Drug product
Achieving pharmaceutical serialisation on a global scale
Insight
  • Manufacturing
2021 packaging trends
Insight
  • Drug substance
Challenges of controlled release formulations
Fact sheet
  • Drug product
Stability studies and analysis for consumer health products